Clinical Trials Browser

Phase 4 × Interventional × Everolimus × Clear all

NCT07426484 2026-02-23

Cosibelimab for CSCC in Patients With Kidney Transplant or Hematologic Malignancy

Phase 4 Not yet recruiting

DermatologicLymphoidOther hematologic neoplasmPlasma cell

Lymphoma, Waldenstrom Macroglobulinemia, Skin Neoplasms, Leukemia, Lymphocytic, Chronic, B-Cell, Neoplasms, Plasma Cell

NCT05252585 2026-02-03

A Phase IV Study of Safety and Efficacy of Everolimus in Taiwanese Patients With Tuberous Sclerosis Complex Who Have Renal Angiomyolipoma (TSC-AML)

Phase 4 Active not recruiting

Tuberous Sclerosis, Angiomyolipoma

NCT02842749 2025-02-10

Phase IV Study of the Safety and Efficacy of Everolimus in Adult Patients With Progressive pNET in China

Phase 4 Completed

61 enrolled 9 charts

EndocrineGastrointestinalNET

Pancreatic Neuroendocrine Tumors

NCT03525834 2021-09-09

Safety and Efficacy of Everolimus (Afinitor®) in Chinese Adult Patients With Angiomyolipoma Associated With Tuberous Sclerosis Complex.

Phase 4 Completed

40 enrolled 10 charts

Tuberous Sclerosis, Lymphangioleiomyomatosis, Angiomyolipoma

NCT01789281 2021-06-11

Everolimus Roll-over Protocol for Patients Who Have Completed a Previous Novartis-sponsored Everolimus Study.

Phase 4 Completed

34 enrolled 8 charts

Carcinoid Tumor, Neoplasms, Neuroendocrine Tumors

NCT01743560 2019-07-18

4EVERUK

Phase 4 Completed

52 enrolled 16 charts

Breast Diseases, Breast Neoplasms, Neoplasms, Skin Diseases

NCT01206764 2019-06-24

A Trial of Everolimis in Patients With Advanced Renal Cell Carcinoma.

Phase 4 Completed

143 enrolled 11 charts

Carcinoma, Renal Cell

NCT01595009 2018-11-29

An Open-label, Multi-center, Expanded Access Study of Everolimus in Participants With Advanced Neuroendocrine Tumors (NETs) (Core Study) and an Extension Study to the Open-label, Multi-center, Expanded Access Study of Everolimus in Patients With Advanced NETs (E1)

Phase 4 Completed

246 enrolled 16 charts

Neuroendocrine Tumors

NCT02338570 2018-02-05

ORCHIDEE

Phase 4 Terminated

Carcinoma, Renal Cell

NCT01266837 2017-11-14

MARC-2

Phase 4 Completed

Carcinoma, Renal Cell

NCT02248571 2017-11-13

IMPROVE

Phase 4 Completed

Breast Neoplasms, Neoplasm Metastasis

NCT01514448 2017-07-19

Safety and Efficacy of Everolimus in Metastatic Renal Cell Carcinoma After Failure of First Line Therapy With Sunitinib or Pazopanib

Phase 4 Completed

29 enrolled 9 charts

Carcinoma, Renal Cell, Kidney Neoplasms

NCT02056587 2014-02-06

Everolimus in Patients With Metastatic Renal Cell Carcinoma Following Progression on Prior Bevacizumab Treatment

Phase 4 Completed

Carcinoma, Renal Cell, Kidney Neoplasms

NCT00903188 2009-05-18

CISTCERT

Phase 4 Unknown

Neoplasms